TAJ (TAJ alpha, Tnfrsf20, Toxicity and JNK Inducer, TRADE, TROY, Tumor Necrosis Factor Receptor Superfamily Member 19, TNFRSF19)

TAJ is a member of the TNF receptor superfamily. This receptor is highly expressed during embryonic development. It has been shown to interact with TRAF family members, and to activate the JNK signaling pathway when overexpressed in cells. This receptor is capable of inducing apoptosis by a caspase-independent mechanism, and it is thought to play an essential role in embryonic development. Alternatively spliced transcript variants encoding distinct isoforms have been described.\n\nApplications: \nSuitable for use in Flow Cytometry. Other applications not tested.\n\nRecommended Dilution:\nFlow Cytometry: 1ug/ml\nOptimal dilutions to be determined by the researcher.\n\nFlow Cytometry Protocol:\n1. 5x10e5 transfected HEK 293T cells were incubated on ice for 30 min in 50ul FACS buffer (PBS, 5% Fetal calf serum, 0.02% azide) containing 1ug/ml of T0721-06.\n2. After washing in FACS buffer, R-PE-conjugated antibody to rat IgG (I1904-74D) was added. \n3. Cells were incubated on ice for 30 min, washed and analyzed by flow cytometry.\n \nStorage and Stability:\nMay be stored at 4 degrees C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20 degrees C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Prices direct from United States Biological

Quick response times

Exclusive Biosave savings/discounts

SPECIFICATIONS

Catalog Number

T0721-06

Size

50ug

Applications

FC

Hosts

Rat

Reactivities

Hum

Form

Supplied as a liquid in PBS, 0.02% sodium azide.

P Type

Mab

Purity

Purified. 95% (SDS-PAGE).

Isotype

IgG

References

1. T. Kojima, et al.; TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with Edar and is expressed in embryonic skin and hair follicles. J. Biol. Chem. 275, 20742 (2000). 2. M.T. Eby, et al.; TAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates caspase-independent cell death. J. Biol. Chem. 275, 15336 (2000). 3. A. Naito, et al.; TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. PNAS 99, 8766 (2002).

Additional Info

Recognizes human Troy.